Optimising TREATment for Severe Gram-Negative Bacterial Infections

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(41 sites)

Australia

Royal Brisbane and Women's Hospital, Brisbane, Queensland

Princess Alexandra Hospital, Brisbane

China

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

The Second Affiliated Hospital, Xi'an Jiang Tong University, Xi'an

Xuzhou First People's Hospital, Xuzhou